What Are Opioids?

Opioids are a class of drugs that relieve pain by binding to opioid receptors in the central and peripheral nervous systems and in the gastrointestinal tract. The class includes compounds extracted from the opium poppy, such as morphine and codeine, semisynthetic derivatives such as oxycodone, hydrocodone, and heroin, and fully synthetic agents such as fentanyl, methadone, and tramadol. The older term opiate refers strictly to the naturally occurring alkaloids, while opioid covers the whole pharmacological class regardless of origin, including the endogenous peptides the body produces itself.

Morphine was isolated from opium by Friedrich Sertürner in the early nineteenth century and became the first alkaloid purified from a plant, which made reproducible dosing possible for the first time. The receptors it acts on were identified in the 1970s, followed shortly by the discovery of enkephalins and endorphins, the body's own opioid ligands. Opioids remain the most effective analgesics available for severe acute pain and for pain at the end of life, and they carry a risk profile that has made their regulation a continuing matter of public health policy.

Receptors and Mechanism of Action

Three principal receptor types mediate opioid effects: mu, kappa, and delta. All three are G protein-coupled receptors that, when activated, inhibit adenylyl cyclase, open potassium channels, and close voltage-gated calcium channels. The result is hyperpolarization of the neuron and reduced release of neurotransmitters that carry pain signals, an effect exerted both presynaptically and postsynaptically. Analgesia arises at several levels of the nervous system at once, in the periaqueductal gray and other supraspinal structures, in the dorsal horn of the spinal cord, and at peripheral nerve terminals. Clinical work on the pharmacological mechanisms of opioid analgesics established that these systems interact synergistically rather than acting in isolation. Mu receptor activation accounts for most of the analgesia produced by clinically used agents and also for euphoria, respiratory depression, constipation, and physical dependence. Kappa activation produces spinal analgesia, sedation, and dysphoria, and delta activation contributes to analgesia and to reduced gastrointestinal motility.

Pharmacology and Clinical Use

Agents in the class differ by receptor affinity, intrinsic activity, and pharmacokinetics rather than by mechanism. Full agonists such as morphine and fentanyl produce a maximal receptor response, partial agonists such as buprenorphine produce a submaximal response and therefore show a ceiling effect on respiratory depression, and antagonists such as naloxone and naltrexone bind without activating and displace agonists already bound. Potency varies over three orders of magnitude, with fentanyl roughly 50 to 100 times more potent than morphine by weight, which is why it is dosed in micrograms. Routes of administration include oral, transdermal, intravenous, epidural, and intrathecal delivery, and formulation strongly affects onset and duration. Beyond analgesia, opioids are used clinically as antitussives, as antidiarrheal agents, and as maintenance treatment for opioid use disorder.

Tolerance, Dependence, and Overdose

Repeated exposure produces tolerance through receptor desensitization and internalization, so an equivalent effect requires an increasing dose, and physical dependence follows, such that abrupt cessation triggers a withdrawal syndrome. Tolerance develops unevenly, and it develops more slowly for respiratory depression than for analgesia, which is the pharmacological basis of overdose risk. Fatal overdose typically results from suppression of the brainstem respiratory drive, an effect greatly amplified by concurrent benzodiazepines or alcohol. Naloxone reverses this by competitively displacing the agonist from the mu receptor, and the naloxone information published by the National Institute on Drug Abuse describes its use in community overdose response. Prescribing practice in the United States has been reshaped by the 2022 CDC clinical practice guideline for prescribing opioids for pain, which followed a period in which prescription volume and overdose mortality rose together.

Applications

Opioid pharmacology intersects with a range of fields, including:

• Perioperative and intensive care medicine, for surgical and procedural analgesia
• Palliative care and cancer pain management
• Emergency medicine and prehospital overdose reversal
• Addiction medicine, including buprenorphine and methadone maintenance
• Drug delivery engineering, covering transdermal patches and implantable pumps
• Public health surveillance and prescription drug monitoring programs